 Veronica Alaniz
Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anorectal Malformations | 7 | 2023 | 109 | 2.690 |
Why?
| | Vagina | 7 | 2024 | 174 | 2.050 |
Why?
| | Gynecology | 6 | 2022 | 174 | 1.810 |
Why?
| | Transgender Persons | 2 | 2022 | 172 | 1.230 |
Why?
| | Urogenital Abnormalities | 3 | 2023 | 52 | 1.120 |
Why?
| | Congenital Abnormalities | 3 | 2022 | 76 | 1.040 |
Why?
| | Intrauterine Devices, Medicated | 2 | 2024 | 28 | 1.020 |
Why?
| | Endometriosis | 1 | 2024 | 46 | 0.850 |
Why?
| | Hymen | 2 | 2022 | 5 | 0.830 |
Why?
| | Leuprolide | 1 | 2022 | 19 | 0.800 |
Why?
| | 46, XX Disorders of Sex Development | 1 | 2022 | 6 | 0.790 |
Why?
| | Contraceptive Agents, Female | 2 | 2024 | 78 | 0.740 |
Why?
| | Disabled Persons | 1 | 2023 | 138 | 0.720 |
Why?
| | Vulvar Lichen Sclerosus | 1 | 2020 | 1 | 0.710 |
Why?
| | Vulvovaginitis | 1 | 2020 | 1 | 0.710 |
Why?
| | Stents | 1 | 2024 | 504 | 0.670 |
Why?
| | Genital Diseases, Female | 2 | 2019 | 27 | 0.660 |
Why?
| | Kidney Diseases | 1 | 2023 | 382 | 0.650 |
Why?
| | Gonadal Dysgenesis | 2 | 2017 | 7 | 0.650 |
Why?
| | Disorders of Sex Development | 2 | 2019 | 38 | 0.650 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2022 | 230 | 0.650 |
Why?
| | Symptom Assessment | 1 | 2020 | 125 | 0.640 |
Why?
| | Lichen Sclerosus et Atrophicus | 1 | 2019 | 3 | 0.640 |
Why?
| | Colitis, Ulcerative | 1 | 2021 | 120 | 0.640 |
Why?
| | Coitus | 1 | 2019 | 25 | 0.620 |
Why?
| | Urethra | 1 | 2019 | 52 | 0.600 |
Why?
| | Female | 35 | 2024 | 68650 | 0.580 |
Why?
| | Breast Cyst | 1 | 2017 | 2 | 0.540 |
Why?
| | Adolescent | 19 | 2024 | 20409 | 0.540 |
Why?
| | Vulvar Diseases | 3 | 2022 | 9 | 0.520 |
Why?
| | Gonads | 1 | 2016 | 23 | 0.510 |
Why?
| | Breast | 1 | 2017 | 140 | 0.500 |
Why?
| | Practice Patterns, Physicians' | 1 | 2024 | 1257 | 0.490 |
Why?
| | Hyperemesis Gravidarum | 1 | 2015 | 4 | 0.480 |
Why?
| | Young Adult | 12 | 2024 | 12438 | 0.480 |
Why?
| | Child | 16 | 2024 | 20932 | 0.460 |
Why?
| | Cannabinoids | 1 | 2015 | 154 | 0.410 |
Why?
| | Humans | 35 | 2024 | 129527 | 0.400 |
Why?
| | Ultrasonography | 1 | 2016 | 708 | 0.390 |
Why?
| | Vaginal Diseases | 2 | 2024 | 21 | 0.380 |
Why?
| | Constriction, Pathologic | 2 | 2024 | 234 | 0.380 |
Why?
| | Marijuana Smoking | 1 | 2015 | 247 | 0.370 |
Why?
| | Adolescent Medicine | 2 | 2022 | 36 | 0.360 |
Why?
| | Internship and Residency | 4 | 2022 | 1049 | 0.340 |
Why?
| | Pregnancy Outcome | 2 | 2023 | 391 | 0.340 |
Why?
| | Retrospective Studies | 10 | 2024 | 14532 | 0.330 |
Why?
| | Cloaca | 2 | 2021 | 48 | 0.320 |
Why?
| | Pediatrics | 3 | 2022 | 1068 | 0.310 |
Why?
| | Adult | 12 | 2023 | 35505 | 0.300 |
Why?
| | Hematometra | 2 | 2023 | 6 | 0.250 |
Why?
| | Gynecologic Surgical Procedures | 3 | 2021 | 57 | 0.250 |
Why?
| | Uterus | 2 | 2023 | 207 | 0.240 |
Why?
| | Ulcer | 2 | 2022 | 28 | 0.240 |
Why?
| | Gonadoblastoma | 1 | 2024 | 6 | 0.230 |
Why?
| | Magnetic Resonance Imaging | 1 | 2016 | 3392 | 0.220 |
Why?
| | Levonorgestrel | 1 | 2024 | 37 | 0.220 |
Why?
| | Hematocolpos | 1 | 2023 | 3 | 0.210 |
Why?
| | Pregnancy | 6 | 2023 | 6412 | 0.200 |
Why?
| | Gynecological Examination | 1 | 2022 | 4 | 0.200 |
Why?
| | Mullerian Ducts | 1 | 2022 | 8 | 0.200 |
Why?
| | Stomatitis, Aphthous | 1 | 2022 | 10 | 0.200 |
Why?
| | Fertility | 1 | 2023 | 155 | 0.190 |
Why?
| | Dilatation | 1 | 2022 | 62 | 0.190 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 5078 | 0.190 |
Why?
| | Focus Groups | 1 | 2024 | 447 | 0.190 |
Why?
| | Menstrual Cycle | 1 | 2022 | 121 | 0.190 |
Why?
| | Goals | 1 | 2023 | 163 | 0.190 |
Why?
| | Delayed Diagnosis | 2 | 2019 | 79 | 0.180 |
Why?
| | Desogestrel | 1 | 2021 | 45 | 0.180 |
Why?
| | Hirschsprung Disease | 1 | 2022 | 84 | 0.180 |
Why?
| | Drug Implants | 1 | 2021 | 82 | 0.180 |
Why?
| | Child, Preschool | 4 | 2020 | 10499 | 0.180 |
Why?
| | Personal Satisfaction | 1 | 2023 | 204 | 0.180 |
Why?
| | Hormones | 1 | 2021 | 140 | 0.180 |
Why?
| | Colon, Sigmoid | 1 | 2021 | 19 | 0.180 |
Why?
| | Tamoxifen | 1 | 2021 | 197 | 0.170 |
Why?
| | Michigan | 1 | 2020 | 104 | 0.170 |
Why?
| | Developmental Disabilities | 1 | 2023 | 242 | 0.170 |
Why?
| | Curriculum | 3 | 2022 | 922 | 0.170 |
Why?
| | Virus Diseases | 1 | 2022 | 210 | 0.160 |
Why?
| | Obstetrics | 1 | 2022 | 162 | 0.160 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 153 | 0.160 |
Why?
| | Laparoscopy | 1 | 2024 | 446 | 0.160 |
Why?
| | Pain | 2 | 2023 | 788 | 0.160 |
Why?
| | Triamcinolone | 1 | 2019 | 15 | 0.160 |
Why?
| | Clobetasol | 1 | 2019 | 7 | 0.160 |
Why?
| | Ointments | 1 | 2019 | 24 | 0.160 |
Why?
| | Kidney | 2 | 2023 | 1382 | 0.160 |
Why?
| | Simulation Training | 1 | 2020 | 82 | 0.160 |
Why?
| | Testosterone | 1 | 2022 | 371 | 0.160 |
Why?
| | Dilatation, Pathologic | 1 | 2019 | 60 | 0.160 |
Why?
| | Educational Measurement | 2 | 2020 | 262 | 0.150 |
Why?
| | Ovarian Neoplasms | 1 | 2024 | 482 | 0.150 |
Why?
| | Genitalia, Female | 1 | 2018 | 38 | 0.150 |
Why?
| | Diagnostic Errors | 1 | 2019 | 162 | 0.150 |
Why?
| | Early Detection of Cancer | 1 | 2022 | 371 | 0.150 |
Why?
| | Middle Aged | 4 | 2023 | 31087 | 0.140 |
Why?
| | Sex Differentiation | 1 | 2017 | 10 | 0.140 |
Why?
| | MAP Kinase Kinase Kinase 1 | 1 | 2017 | 19 | 0.140 |
Why?
| | Transition to Adult Care | 1 | 2018 | 81 | 0.140 |
Why?
| | Hemorrhage | 1 | 2021 | 680 | 0.140 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 514 | 0.130 |
Why?
| | Postoperative Complications | 3 | 2024 | 2475 | 0.130 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 5429 | 0.130 |
Why?
| | Castration | 1 | 2016 | 14 | 0.130 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2016 | 6 | 0.130 |
Why?
| | Prospective Studies | 3 | 2023 | 7150 | 0.130 |
Why?
| | Cysts | 1 | 2017 | 108 | 0.120 |
Why?
| | Caregivers | 1 | 2023 | 807 | 0.120 |
Why?
| | Perinatal Care | 1 | 2016 | 55 | 0.120 |
Why?
| | Body Mass Index | 1 | 2024 | 2269 | 0.120 |
Why?
| | Adolescent Health Services | 1 | 2016 | 74 | 0.120 |
Why?
| | Baths | 1 | 2015 | 15 | 0.120 |
Why?
| | Pregnancy in Adolescence | 1 | 2016 | 80 | 0.120 |
Why?
| | Abortion, Induced | 1 | 2017 | 99 | 0.120 |
Why?
| | Colorectal Neoplasms | 1 | 2022 | 744 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1422 | 0.120 |
Why?
| | Glucocorticoids | 1 | 2019 | 583 | 0.110 |
Why?
| | Male | 7 | 2022 | 63586 | 0.110 |
Why?
| | Clinical Competence | 1 | 2020 | 1015 | 0.100 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2016 | 250 | 0.100 |
Why?
| | Mental Health Services | 1 | 2016 | 400 | 0.090 |
Why?
| | Patient-Centered Care | 1 | 2016 | 501 | 0.090 |
Why?
| | Patient Acceptance of Health Care | 1 | 2017 | 761 | 0.090 |
Why?
| | Aged, 80 and over | 1 | 2022 | 7052 | 0.090 |
Why?
| | Cohort Studies | 1 | 2020 | 5423 | 0.080 |
Why?
| | Time Factors | 1 | 2020 | 6530 | 0.080 |
Why?
| | Mothers | 1 | 2016 | 731 | 0.080 |
Why?
| | Intrauterine Device Expulsion | 1 | 2024 | 9 | 0.060 |
Why?
| | Vaccination | 2 | 2022 | 1348 | 0.050 |
Why?
| | Databases, Factual | 2 | 2019 | 1261 | 0.050 |
Why?
| | Aged | 1 | 2022 | 22063 | 0.050 |
Why?
| | Radiology, Interventional | 1 | 2023 | 30 | 0.050 |
Why?
| | Urogenital System | 1 | 2022 | 16 | 0.050 |
Why?
| | Vulva | 1 | 2022 | 24 | 0.050 |
Why?
| | Drainage | 1 | 2023 | 164 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2020 | 269 | 0.040 |
Why?
| | Hydrocolpos | 1 | 2019 | 6 | 0.040 |
Why?
| | Perineum | 1 | 2019 | 26 | 0.040 |
Why?
| | Genitalia | 1 | 2019 | 30 | 0.040 |
Why?
| | United States | 3 | 2022 | 13865 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2018 | 21 | 0.040 |
Why?
| | Rectal Prolapse | 1 | 2018 | 21 | 0.040 |
Why?
| | Urologic Diseases | 1 | 2018 | 39 | 0.040 |
Why?
| | Digestive System Surgical Procedures | 1 | 2018 | 98 | 0.040 |
Why?
| | Fecal Incontinence | 1 | 2018 | 80 | 0.040 |
Why?
| | Abortifacient Agents, Steroidal | 1 | 2017 | 5 | 0.040 |
Why?
| | Dilatation and Curettage | 1 | 2017 | 11 | 0.040 |
Why?
| | Lost to Follow-Up | 1 | 2017 | 21 | 0.030 |
Why?
| | Mifepristone | 1 | 2017 | 64 | 0.030 |
Why?
| | Colorado | 2 | 2018 | 4403 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 2017 | 77 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 278 | 0.030 |
Why?
| | Reference Values | 1 | 2018 | 795 | 0.030 |
Why?
| | Reoperation | 1 | 2019 | 542 | 0.030 |
Why?
| | Pedigree | 1 | 2017 | 482 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1548 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2017 | 275 | 0.030 |
Why?
| | Depression, Postpartum | 1 | 2016 | 126 | 0.030 |
Why?
| | Program Development | 1 | 2016 | 354 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3081 | 0.030 |
Why?
| | Parenting | 1 | 2016 | 294 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1500 | 0.020 |
Why?
| | Program Evaluation | 1 | 2016 | 873 | 0.020 |
Why?
| | Mental Health | 1 | 2016 | 687 | 0.020 |
Why?
| | Parents | 1 | 2017 | 1309 | 0.020 |
Why?
| | Physicians | 1 | 2017 | 872 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 5769 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 3702 | 0.020 |
Why?
| | Infant | 1 | 2019 | 9005 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10232 | 0.010 |
Why?
|
|
Alaniz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|